A new twist on an old problem: primary care physicians and results from direct-to-consumer genetic testing

Papers of special note have been highlighted as: ▪ of interest ▪▪ of considerable interest

References

• 1  Offit K. Personalized medicine: new genomics, old lessons. Human Genet.130(1),3–14 (2011).
  MedlineGoogle Scholar
• 2  Singleton A, Erby LH, Foisie KV, Kaphingst KA. Informed choice in direct-to-consumer genetic testing (DTCGT) websites: a content analysis of benefits, risks, and limitations. J. Genet. Counsel.21(3),433–439 (2012).
  MedlineGoogle Scholar
• 3  Hunter D, Khoury M. Letting the genome out of the bottle – will we get our wish? N. Engl. J. Med.358,105–107 (2008).
  Medline CASGoogle Scholar
• 4  Putting DNA to the test. Nature461(7265),697–698 (2009).
  Google Scholar
• 5  Howard HC, Borry P. Survey of European clinical geneticists on awareness, experiences and attitudes towards direct-to-consumer genetic testing. Genome Med.5(5),45 (2013).
  MedlineGoogle Scholar
• 6  Wright CF, Gregory-Jones S. Size of the direct-to-consumer genomic testing market. Genet. Med.12(9),594 (2010).
  MedlineGoogle Scholar
• 7  Kolor K, Duquette D, Zlot A et al. Public awareness and use of direct-to-consumer personal genomic tests from four state population-based surveys, and implications for clinical and public health practice. Genet. Med.14(10),860–867 (2012).
  MedlineGoogle Scholar
• 8  Finney Rutten LJ, Gollust SE, Naveed S, Moser RP. Increasing public awareness of direct-to-consumer genetic tests: health care access, internet use, and population density correlates. J. Cancer Epidemiol.2012(2),1–7 (2012).
  Google Scholar
• 9  Medical Profiling and Online Medicine. Nuffield Council on Bioethics, London, UK (2010).
  Google Scholar
• 10  Foster MW, Sharp RR. Out of sequence: how consumer genomics could displace. Clin. Genet. Nat. Rev. Genet.9(6),419 (2008).
  Medline CASGoogle Scholar
• 11  Kolor K, Liu T, St Pierre J, Khoury MJ. Health care provider and consumer awareness, perceptions, and use of direct-to-consumer personal genomic tests, United States, 2008. Genet. Med.11(8),595 (2009).
  MedlineGoogle Scholar
• 12  Goldsmith L, Jackson L, O‘Connor A, Skirton H. Direct-to-consumer genomic testing: systematic review of the literature on user perspectives. Eur. J. Hum. Genet.20(8),811–816 (2012).
  MedlineGoogle Scholar
• 13  McGuire A, Burke W. Health system implications of direct-to-consumer personal genome testing. Public Health Genomics14(1),53–58 (2010).
  MedlineGoogle Scholar
• 14  Caulfield T, McGuire AL. Direct-to-consumer genetic testing: perceptions, problems, and policy responses. Annu. Rev. Med.63(1),23–33 (2012).
  Medline CASGoogle Scholar
• 15  Brett GR, Metcalfe SA, Amor DJ, Halliday JL. An exploration of genetic health professionals‘ experience with direct-to-consumer genetic testing in their clinical practice. Eur. J. Hum. Genet.20(8),825–830 (2012).
  MedlineGoogle Scholar
• 16  Allison M. Direct-to-consumer genomics reinvents itself. Nat. Biotechnol.30(11),1027–1029 (2012).
  Medline CASGoogle Scholar
• 17  Howard HC, Borry P. Is there a doctor in the house? J. Commun. Genet.3(2),105–112 (2011).
  MedlineGoogle Scholar
• 18  Powell KP, Cogswell WA, Christianson CA et al. Primary care physicians‘ awareness, experience and opinions of direct-to-consumer genetic testing. J. Genet. Counsel.21(1),113–126 (2012).▪▪ Large survey of US primary care physicians evaluating awareness and experience with direct-to-consumer genetic testing (DTC-GT). Already, almost 20% of respondents had patients asking about DTC-GT and the authors conclude there is a real need for education about genetic testing for primary care physicians.
  MedlineGoogle Scholar
• 19  Borry P, Cornel MC, Howard HC. Where are you going, where have you been: a recent history of the direct-to-consumer genetic testing market. J. Commun. Genet.1(3),101–106 (2010).
  MedlineGoogle Scholar
• 20  Bartlett G, Antoun J, Zgheib NK. Theranostics in primary care: pharmacogenomics tests and beyond. Expert Rev. Mol. Diagn.12(8),841–855 (2012).▪ Review of the current scope of personalized medicine, particularly in relation to primary care with several recommendations to ensure optimal implementation.
  Medline CASGoogle Scholar
• 21  Janssens AC, Gwinn M, Bradley LA, Oostra BA, van Duijn CM, Khoury MJ. A critical appraisal of the scientific basis of commercial genomic profiles used to assess health risks and personalize health interventions. Am. J. Hum. Genet.82(3),593–599 (2008).▪▪ Excellent review of current DTC-GT companies with a summary of the scientific evidence that does or does not support the claims of the companies.
  Medline CASGoogle Scholar
• 22  Thorogood A, Knoppers B, Dondorp W, de Wert G. Whole-genome sequencing and the physician. Clin. Genet.81(6),511–513 (2012).▪▪ Explores the role of whole-genome sequencing and the physicians‘ professional obligations.
  Medline CASGoogle Scholar
• 23  Berg C, Fryer-Edwards K. The ethical challenges of direct-to-consumer genetic testing. J. Bus Ethics77(1),17–31 (2007).
  Google Scholar
• 24  Wade CH, Wilfond BS. Ethical and clinical practice considerations for genetic counselors related to direct-to-consumer marketing of genetic tests. Am. J. Med. Genet. C Semin. Med. Genet.142C(4),284–292; discussion 293 (2006).
  MedlineGoogle Scholar
• 25  Howard HC, Borry P. Personal genome testing: do you know what you are buying? Am. J. Bioethics9(6–7),11–13 (2009).
  MedlineGoogle Scholar
• 26  Vogenberg FR, Barash CI, Pursel M. Personalized medicine: part 3: challenges facing health care plans in implementing coverage policies for pharmacogenomic and genetic testing. Pharm. Ther.35(12),670–675 (2010).
  Google Scholar
• 27  Bloss CS, Schork NJ, Topol EJ. Effect of direct-to-consumer genome-wide profiling to assess disease risk. N. Engl. J. Med.364(6),524–534 (2011).
  Medline CASGoogle Scholar
• 28  Council European Academies Science Advisory Board, Medicine FOEAO. Direct-to-consumer genetic testing for health-related purposes in the European Union. EASAC policy report 18. DVZ-Daten-Service GmbH, Halle/Saale, Germany (2012).
  Google Scholar
• 29  Bunnik E, Janssens A, Schermer M. Informed consent in direct-to-consumer personal genome testing: the outline of a model between specific and generic consent. Bioethics doi: 10.1111/bioe.12004 (2012) (Epub ahead of print).
  Google Scholar
• 30  Borry P, Howard HC, Sénécal K, Avard D. Direct-to-consumer genome scanning services. Also for children? Nat. Rev. Genet.10(1),8 (2009).
  Medline CASGoogle Scholar
• 31  McGuire AL, Diaz CM, Wang T, Hilsenbeck SG. Social networkers‘ attitudes toward direct-to-consumer personal genome testing. Am. J. Bioethics9(6–7),3–10 (2009).
  MedlineGoogle Scholar
• 32  Schmidt C. Regulators weigh risks of consumer genetic tests. Nat. Biotechnol.26(2),145–146 (2008).
  Medline CASGoogle Scholar
• 33  Katsanis SH, Javitt G, Hudson K. Public health. A case study of personalized medicine. Science320(5872),53–54 (2008).
  Medline CASGoogle Scholar
• 34  Kutz G. Direct-to-consumer genetic tests: misleading test results are further complicated by deceptive marketing and other questionable practices. United States Government Accountability Office, Washington, DC, USA (2010)
  Google Scholar
• 35  Allison M. Genetic testing clamp down. Nat. Biotechnol.28(7),633 (2010).
  Medline CASGoogle Scholar
• 36  Borry P, Howard HC, Sénécal K, Avard D. Health-related direct-to-consumer genetic testing: a review of companies‘ policies with regard to genetic testing in minors. Fam. Cancer9(1),51–59 (2009).▪▪ Review of the policies of the DTC-GT companies regarding minors.
  MedlineGoogle Scholar
• 37  Howard HC, Avard D, Borry P. Are the kids really all right? Eur. J. Hum. Genet.19(11),1122–1126 (2011).▪ Survey of 37 DTC-GT companies regarding their policies concerning the testing of minors. The authors conclude that the majority of companies offer this service to minors and emphasize the need for appropriate standards of practice.
  MedlineGoogle Scholar
• 38  Tamir S. Direct-to-consumer genetic testing: ethical–legal perspectives and practical considerations. Med. Law Rev.18(2),213–238 (2010).
  MedlineGoogle Scholar
• 39  Mills P. The sense of proportion: two thoughts about the governance of direct-to-consumer genetic testing for children. Genomics Soc. Policy6(3),71–73 (2010).
  Google Scholar
• 40  Tarini BA, Tercyak KP, Wilfond BS. Commentary: children and predictive genomic testing: disease prevention, research protection, and our future. J. Pediatr. Psychol.36(10),1113–1121 (2011).▪ Balanced presentation of the different points of view in the debate for DTC-GT in children.
  MedlineGoogle Scholar
• 41  Green RC, Berg JS, Grody WW et al. ACMG recommendations for reporting of incidental findings in clinical exome and genome sequencing. Genet. Med.15(7),565–574 (2013).
  Medline CASGoogle Scholar
• 42  Black L, McClellan KA. Familial communication of research results: a need to know? J. Law Med. Ethics39(4),605–613 (2011).
  MedlineGoogle Scholar
• 43  Black L, McClellan KA, Avard D, Knoppers BM. Intrafamilial disclosure of risk for hereditary breast and ovarian cancer: points to consider. J. Commun. Genet.4(2),203–214 (2012).
  MedlineGoogle Scholar
• 44  Bartlett G, Zgheib N, Manamperi A et al. Pharmacogenomics in primary care: a crucial entry point for global personalized medicine? Curr. Pharmacogenomics Per. Med.10(2),101–105 (2012).
  CASGoogle Scholar
• 45  Goldsmith L, Jackson L, O‘Connor A, Skirton H. Direct-to-consumer genomic testing from the perspective of the health professional: a systematic review of the literature. J. Commun. Genet.4(2),169–180 (2013).
  MedlineGoogle Scholar
• 46  Reid RJ, McBride CM, Alford SH et al. Association between health-service use and multiplex genetic testing. Genet. Med.14(10),852–859 (2012).
  MedlineGoogle Scholar
• 47  Skirton H, Goldsmith L, Jackson L, O‘Connor A. Direct to consumer genetic testing: a systematic review of position statements, policies and recommendations. Clin. Genet.82(3),210–218 (2012).
  Medline CASGoogle Scholar
• 101  Dictionary of cancer terms. National Cancer Institute. www.cancer.gov/dictionary?561717
  Google Scholar
• 102  Questions and answers. National Center for Biotechnology Institute. www.ncbi.nlm.nih.gov/gtr/qa
  Google Scholar
• 103  23andMe. www.23andme.com/health
  Google Scholar
• 104  Navigenics^®. www.navigenics.com
  Google Scholar
• 105  Assessing the direct-to-consumer genetic testing results of your patient. National Health and Medical Research Council. http://consultations.nhmrc.gov.au/files/consultations/drafts/assessingthedirect-consumerdtcgenetictestingofyourpatientdraft.pdf
  Google Scholar
• 106  Centre GAPP. Direct to Consumer Genetic Testing Companies. Genetics and Public Policy Centre. www.dnapolicy.org/resources/DTCcompanieslist.pdf
  Google Scholar